ONYDA XR
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2026)
What this means for you
This application is over — abandoned 23 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98698414
- Mark type
- Design + words
- Filed
- 14 Aug 2024
- Published for opposition
- 24 Jun 2025
- Abandoned
- 23 Mar 2026
- Attorney of record
- Cathy Kodroff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder
Owner
- TRIS PHARMA, INC., Monmouth Junction, NJ, US
- TRIS PHARMA, INC., Monmouth Junction, NJ, US
Prosecution history
- 23 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Feb 2025 — NON-FINAL ACTION E-MAILED
- 27 Feb 2025 — NON-FINAL ACTION WRITTEN
- 27 Feb 2025 — ASSIGNED TO EXAMINER
- 26 Feb 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED